Ophthalmology Researcher Named Chair of NIH Study Section

Group reviews research grant applications for scientific merit

Released: 27-Aug-2014 1:00 PM EDT
Source Newsroom: University of Louisville
Contact Information

Available for logged-in reporters only

Newswise — A professor in the Department of Ophthalmology and Visual Sciences in the University of Louisville School of Medicine has been named chair of a panel that reviews research grant applications, helping determine which are worthy for support from the National Institutes of Health.

Maureen McCall, Ph.D., has been named chair of the 20-member Neurotransporters, Receptors and Calcium Signaling Study Section of the NIH’s Center for Scientific Review. She is the only Kentuckian on the panel, which has representatives from universities in 14 states. Her term begins this month (August 2014) and will conclude in 2016.

The Center for Scientific Review is the gateway for NIH grant applications and their review for scientific merit. It recruits and organizes scientists into 174 study sections to review applications for funding made to the NIH.

Each study section has a precise focus so that applications receive expert reviews to help the NIH identify the most promising research. The Neurotransporters, Receptors and Calcium Signaling Study Section reviews studies that investigate signal transduction pathways in neurons, muscles and other excitable cells – those that can be stimulated to create an electric current.

McCall holds joint appointments as professor in the Departments of Anatomical Sciences and Neurobiology and Psychological and Brain Sciences. She came to UofL in 1997.

The author of approximately 60 journal articles, McCall uses electrophysiological techniques in her research to evaluate normal retinal function, dysfunction caused by blinding retinal diseases, and the restoration of function using a variety of therapeutic strategies. Particular areas of emphasis are in the study of retinitis pigmentosa, glaucoma and congenital stationary night blindness.


Comment/Share